Siavash Atrchian, MD, FRCPC

Clinical Assistant Professor, Division of Radiation Oncology and Developmental Radiotherapeutics, UBC Department of Surgery, Radiation Oncologist, BC Cancer, Kelowna, BC

Dr. Siavash Atrchian is a Radiation Oncologist at BC Cancer Kelowna and a Clinical Assistant Professor in the Faculty of Medicine at the University of British Columbia. Dr. Atrchian specializes in Lung, Breast and Gastrointestinal tumor sites, with a special interest in Stereotactic Ablative Radiotherapy(SABR). He is the principal investigator and co-principal investigator of multiple current research studies. His research interests include: Deep Learning Applications in Radiation Oncology, SABR, Outcomes of Cancer Treatment and the role of Microbiome in cancer development.
https://surgery.med.ubc.ca/people/s-atrchian/

Dr. Alexander Louie, MD, PhD, M.Sc., FRCPC

Dr. Louie’s academic focus is the use of comparative effectiveness research in lung, kidney and oligometastatic cancers. He has expertise in clinical trials, patient-reported outcomes, population databases, decision analyses, health economics and technological appraisals.

Houda Bahig, MDCM, PH.D.

Associate Professor, Department of Radiology, Radiation Oncology & Nuclear Medicine, Université de Montréal, Radiation Oncologist, CHUM, Montreal, QC

Dr Bahig specializes in the treatment of head and neck cancers and lung cancers, with a special interest for the development of pragmatic clinical trials evaluating new technological approaches to individualize radiotherapy. She also works on the development of algorithms using artificial intelligence to predict the response and side effects of head and neck, and thoracic radiotherapy.

Benjamin Mou, MD, FRCPC

Clinical Assistant Professor, University of British Columbia, Radiation Oncologist, BC Cancer, Kelowna, BC

Dr. Mou is a radiation oncologist at BC Cancer Kelowna and clinical assistant professor at the University of British Columbia. He is the chair of the Stereotactic and Lung Technical Site Teams in Kelowna and the Chair of the Provincial Lung Radiation Oncology Group in BC. He specializes in SABR and radiosurgery for multiple body sites with a particular interest in Lung, CNS, and GI malignancies. He serves as the site principal investigator in Kelowna for multiple SABR clinical trials and is involved provincially in the clinical implementation and advancement of lung and spine SABR in BC.

Andrea Bezjak, MDCM, FRCPC

Dr. Andrea Bezjak is a Professor in the Departments of Radiation Oncology and Clinical Epidemiology & Health Care Research at the University of Toronto, Canada and staff radiation oncologist at the Princess Margaret Cancer Center/University Health Network, specializing in thoracic malignancies and management of extra-cranial metastatic disease. She has held a number of leadership positions locally and nationally, including being the PMH Cancer Program Site Group Leader (2009-16), the inagural Addie MacNaughton Chair in Thoracic Radiation Oncology at the University of Toronto (2004-19), President of CARO (Canadian Association of Radiation Oncology, 2011-13) and Chair of the NCIC CTG Quality of Life Committee (1996-2006).

She has authored or co-authored more than 240 peer reviewed manuscripts and has bee a principal investigator of multi-center clinical trials in lung cancer. Her current positions include being the Radiation Oncology Residency Program Director at the University of Toronto, Medical Director of the Princess Margaret Cancer Care Network, Board Member and Secretary of the Board of IASLC (International Association for Study of Lung Cancer) and Secretary (previously Chair) of CROF (Canadian Radiation Oncology Foundation).

Laura Dawson, MD, FRCPC, FASTRO

Professor, Department of Radiation Oncology, University of Toronto, Radiation Oncologist, PMH, Toronto, ON

Dr. Laura Dawson is a Professor in the Department of Radiation Oncology at the University of Toronto, and a practicing radiation oncologist at the Radiation Medicine Program, Princess Margaret Cancer Centre, in Toronto. She is the multi-disciplinary hepatobiliary cancer and pancreatic cancer site lead for the Princess Margaret Cancer Committee. She is an internationally recognized leader in hepatocellular carcinoma and in oligo-metastases stereotactic body radiation therapy (SBRT). She is the principal investigator of two randomized phase III clinical trials investigating the use of radiation therapy in hepatocellular carcinoma (RTOG1112 and CCTG HE1).

Brian Keller, PhD, DABR, FCCPM
Dr Brian Keller is a senior medical physicist at the Sunnybrook Odette Cancer Centre in Toronto and an Assistant Professor in the Department of Radiation Oncology at the University of Toronto. He has been involved with MR-Linac technology since 2012 and was instrumental in the implementation of the first clinical machine in Canada. He has research interests on the effects of magnetic fields on radiation dose and pursuing the benefits that MR-Linac technology may offer. His clinical sites are breast, lung, and GI.

Patrick Cheung, MD, FRCPC

Dr. Patrick Cheung is a Radiation Oncologist at the Sunnybrook Odette Cancer Centre, specializing in genito-urinary and lung malignancies and the treatment of oligometastases/oligoprogression. He is an Associate Professor in the Department of Radiation Oncology at the University of Toronto. His academic interests include evaluating the role of stereotactic body radiotherapy (SBRT) in the setting of metastatic cancer. He currently is the co-chair of CCTG PR.20, which is a national phase 3 trial comparing systemic therapy vs systemic therapy plus SBRT for hormone sensitive oligometastatic prostate cancer.

Dr. Sten Myrehaug, MD, FRCPC

Dr. Sten Myrehaug received his Doctor of Medicine degree at the University of Alberta in 2005. In 2010, he completed his post-graduate training in radiation oncology at the University of Toronto, and subsequently did a clinical research fellowship at the National Institutes of Health in Bethesda, Maryland. In 2015 he joined the staff at the Odette Cancer Centre and is an Assistant Professor in the Department of Radiation Oncology at the University of Toronto. His clinical interest is the management of both CNS and gastrointestinal malignancies, with a focus on the utilization of stereotactic body radiation techniques and management of neuroendocrine tumors.

Robert Olson, MD, FRCPC, MSc

Rob Olson is a Radiation Oncologist and researcher who practices in BC Cancer - Prince George. He is the Division Head of Radiation Oncology and the Associate Head of Research in the Department of Surgery, both at UBC. His primary research focus is on SABR in the setting of metastatic disease, and is the principal investigator on several SABR clinical trials, including SABR-5 and SABR-COMET-3.

Gregory M. M. Videtic, MDCM, FRCPC, FACR, FASTRO

Professor of Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Staff Physician, Department of Radiation Oncology, Cleveland Clinic’s Taussig Cancer Institute, Cleveland, OH

Dr. Videtic is a Staff Physician in the Department of Radiation Oncology of the Cleveland Clinic’s Taussig Cancer Institute and a Professor of Medicine at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University.
He was born in Montreal and attended McGill University where he obtained a B.Sc. with Honors in Physiology, followed by completion of his medical degree. He completed a Residency in Family Medicine at Dalhousie University in Halifax, Nova Scotia, in 1988. He completed a Research Fellowship in Geriatrics at the University of Western Ontario in 1992 then returned there for a Residency in Radiation Oncology, completing it in 1997. He completed a CNS Radiosurgery/Brachytherapy Fellowship in 1998 at Wayne State University in Detroit, MI, under the mentorship of Dr. Laurie Gaspar.
His first staff position was at the London Regional Cancer Centre in London, Ontario. He then moved to the Dana-Farber Cancer Institute, Boston, MA, in 2000, followed by a move to the Cleveland Clinic’s Department of Radiation Oncology in 2003. At the Clinic, he is currently the Director of Thoracic Radiation Oncology, with primary responsibility to leading the lung stereotactic body radiotherapy program since its inception in 2004.
Among other affiliations, he is a member of the Lung Cancer Steering Committee of the Radiation Therapy Oncology Group (RTOG) and was the Principal Investigator for RTOG 0915. He was Senior Editor (Thoracic) for the “International Journal of Radiation Oncology, Biology, Physics” from 2013 to 2016 and is an Executive Editor at “ASTRO’s Advances in Radiation Oncology” Journal since 2016.

Dr. David Palma, MD, PhD, FRCPC
Professor, Western University
Radiation Oncologist, London Health Sciences Centre

Dr. David Palma, MD, PhD is a Professor and Radiation Oncologist at Western University in London, Canada. He holds an MD from the University of Western Ontario, a Master’s Degree in Epidemiology from the Harvard School of Public Health, and a PhD from the VU University in Amsterdam. He has led several international randomized trials in radiation oncology, and he is the chair of the Canadian Pulmonary Radiotherapy Investigators (CAPRI) group. He is the author of the bestselling book Taking Charge of Cancer: What You Need to Know to Get the Best Treatment.

Dr. Bergman is a senior medical physicist at BC Cancer - Vancouver and Fellow of the Canadian College of Physicists in Medicine. She has been in the thick of the rapid expansion of the stereotactic body radiotherapy (SABR) program at BC Cancer. She has seen the Vancouver program grow from 14 lung SABR patients in 2009 to an extensive multi-site program, treating over 300 SABR patients/year. Alanah has been super excited to have BC Cancer participate in several landmark Canadian-led SABR Trials. Her interests currently lie with motion management for lung and liver SABR and she is the lead physicist for the BC Cancer Dynamic Tumour Tracking program. Her current work includes expanding the fiducial-based Liver SABR tracking program and implementing a fiducial-LESS tracking program for Lung and Liver. She is also interested in re-treatment planning workflows, particularly in the SABR context.

Tanya Berrang, MD, FRCPC

Clinical Associate Professor, University of British Columbia Radiation Oncologist, BC Cancer Victoria, BC

Dr. Berrang is a Clinical Associate Professor with the University of British Columbia and staff radiation oncologist at BC Cancer Victoria. Her areas of special interest include breast cancer, lung cancer, multi-site SABR for oligo metastatic disease and quality improvement. She is currently a member of the NCI Breast Oncology Local Disease (BOLD) Task Force and co-chair of the BC Cancer Victoria Quality Committee. Her roles in clinical trials includes BC provincial principle investigator for several breast cancer trials and site principle investigator for multiple clinical trials assessing the use of SABR for oligo metastatic disease.

Mitchell C.C. Liu, MDCM, FRCPC

Clinical Professor of Radiation Oncology, Department of Surgery, University of British Columbia, Vancouver, BC

Mitchell C.C. Liu, MDCM, FRCPC is a Clinical Professor of Radiation Oncology in the Department of Surgery, University of British Columbia.
Dr. Liu completed his radiation oncology residency at McGill University and a radiation oncology fellowship at Massachusetts General Hospital in Boston.
He practices at the BC Cancer, Vancouver Centre and he is the Lung Cancer Site Team Lead at Vancouver.
Dr. Liu is one of the leaders at BC Cancer for SABR (Lung, Liver, Spine, and Oligometastases); and specialized in risk factors and predictive models for radiation therapy complications.
He is involved in SABR-COMET, SC24, SABR-5, COMET-3, and in charge of the OAR constraints in BC Cancer guidelines, SABR-5 and COMET-3.

Devin Schellenberg, BSc MD FRCPC

Clinical Associate Professor, University of British Columbia, Department Head of Radiation Oncology, BC Cancer Surrey Centre, Radiation Oncologist, BC Cancer, Surrey, BC

Dr. Devin Schellenberg completed medical school and Residency at the University of BC and University of Toronto. He went onto a Fellowship at Stanford University and has been the Department Head of Radiation Oncology at the BC Cancer Surrey Centre for the past 4 years. He chairs the Lung Radiation Oncology working group with CCTG and is a founding member of CAPRI (Canadian Pulmonary Radiotherapy Investigators Group).
He has been a leader in BC Cancer’s Stereotactic Ablative Body Radiotherapy (SABR) programs and his current research efforts focus on how radiation can alter the course of metastatic disease and (outside of cancer) whether radiation is able to treat heart arrhythmias.